+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Physician Dispensed Cosmeceuticals - Global Strategic Business Report

  • PDF Icon

    Report

  • 515 Pages
  • March 2024
  • Region: Global
  • Global Industry Analysts, Inc
  • ID: 2228061

Global Physician Dispensed Cosmeceuticals Market to Reach $37.3 Billion by 2030

The global market for Physician Dispensed Cosmeceuticals estimated at US$18 Billion in the year 2022, is projected to reach a revised size of US$37.3 Billion by 2030, growing at a CAGR of 9.5% over the analysis period 2022-2030. Skin Care, one of the segments analyzed in the report, is projected to record 10.7% CAGR and reach US$17.4 Billion by the end of the analysis period. Growth in the Hair Care segment is estimated at 9.2% CAGR for the next 8-year period.

The U.S. Market is Estimated at $6.7 Billion, While China is Forecast to Grow at 11.8% CAGR

The Physician Dispensed Cosmeceuticals market in the U.S. is estimated at US$6.7 Billion in the year 2022. China, the world's second largest economy, is forecast to reach a projected market size of US$3.1 Billion by the year 2030 trailing a CAGR of 11.8% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 8.1% and 8.7% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 8.7% CAGR.

Select Competitors (Total 120 Featured)

  • Allergan Aesthetics
  • Cardinal Health, Inc.
  • Bayer AG
  • Amway Corporation
  • Beiersdorf AG
  • Clinique Laboratories LLC
  • Allergan PLC
  • Cosmeceuticals International Inc.
  • Cellex-C International, Inc.
  • ALASTIN Skincare, Inc.
  • A. Menarini Asia-Pacific Holdings Pte., Ltd.
  • Athena Cosmetics, Inc.
  • Cosmedical Technologies LLC
  • Bausch Health Companies Inc.
  • Cosmetic Skin Solutions LLC

Economic Outlook

The global economic outlook is improving, and growth recovery, albeit on the lower side, is expected for this year and the next. The United States although witnessing slowing GDP growth in response to tight monetary and financial conditions, has nevertheless overcome the recession threat. Easing of headline inflation in Euro area is helping boost real incomes and is contributing to pick-up in economic activity. China is expected to see strong increases in GDP in the coming year as the pandemic threat recedes and the government sheds its zero-COVID policy. With optimistic GDP projections, India remains on-course to emerge into a US trillion economy by 2030, surpassing Japan and Germany.

The upturn, however, remains fragile and a number of interlocking challenges continue to run in parallel, such as continued uncertainty around the war in Ukraine; slower than expected decline in global headline inflation; continuation of food and fuel inflation as a persistent economic problem for most developing countries; and still high retail inflation and its impact on consumer confidence and spending. Countries and their governments are showing signs of weathering these challenges, which helps lift market sentiments. As governments continue to combat inflation to get it down to more economically conformable levels by raising interest rates, new job creation will slowdown and impact economic activity. Stricter regulatory environment and pressure to mainstream climate change into economic decisions will compound the complexity of challenges faced.

Although corporate investments can likely be held back by inflation worries and weaker demand, rise of new technologies will reverse partially this prevailing investment sentiment. Rise of generative AI; applied AI; industrializing machine learning; next-generation software development; Web3; cloud and edge computing; quantum technologies; electrification and renewables and climate technologies beyond electrification and renewables, will open up the global investment landscape. The technologies hold the potential to drive sizeable incremental growth and value to global GDP in the coming years. The short-term is expected to be a mixed bag of challenges and opportunities for both consumers and investors alike. There is always opportunity for businesses and their leaders who can chart a path forward with resilience and adaptability.

What`s New?

  • Special discussions on the global economic climate and market sentiment
  • Coverage on global competitiveness and key competitor percentage market shares
  • Market presence analysis across multiple geographies - Strong/Active/Niche/Trivial
  • Online interactive peer-to-peer collaborative bespoke updates
  • Access to digital archives and trademarked research platform
  • Complimentary updates for one year
  • Access to curated YouTube video transcripts of market sentiments shared by CEOs, domain experts and market influencers via interviews, podcasts, press statements and event keynotes
Frequently Asked Questions about the Physician Dispensed Cosmeceuticals Market

What is the estimated value of the Physician Dispensed Cosmeceuticals Market?

The Physician Dispensed Cosmeceuticals Market was estimated to be valued at $18 Billion in 2022.

What is the growth rate of the Physician Dispensed Cosmeceuticals Market?

The growth rate of the Physician Dispensed Cosmeceuticals Market is 9.5%, with an estimated value of $37.3 Billion by 2030.

What is the forecasted size of the Physician Dispensed Cosmeceuticals Market?

The Physician Dispensed Cosmeceuticals Market is estimated to be worth $37.3 Billion by 2030.

Who are the key companies in the Physician Dispensed Cosmeceuticals Market?

Key companies in the Physician Dispensed Cosmeceuticals Market include Allergan Aesthetics, Cardinal Health, Inc., Bayer AG, Amway Corporation, Beiersdorf AG, Clinique Laboratories LLC, Allergan PLC, Cosmeceuticals International Inc., Cellex and C International, Inc..

Table of Contents

I. METHODOLOGYII. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
  • Impact of COVID-19 Pandemic and Looming Global Recession
  • World Economic Growth Projections (Real GDP, Annual % Change) for 2020 through 2022
  • The Global Beauty Industry Recovers Cautiously from the Pandemic Impact
  • Global Beauty Sector Percentage YoY Growth: 2016 to 2024
  • Dermatology Practices amid the Pandemic
  • A Peek into Future Skincare Trends
  • Beauty-from-Within Trend Scripts Inventive Plays for Cosmeceuticals & Delivery Formats
  • Competition
  • Physician Dispensed Cosmeceuticals - Global Key Competitors Percentage Market Share in 2022 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2022 (E)
  • An Introduction to Physician-Dispensed Cosmeceuticals
  • Types of Physician-Dispensed Cosmeceuticals
  • Select Major Ingredients Used in Physician-Dispensed Cosmeceuticals
  • Physician Dispensed Cosmeceuticals: Delivering Health and Beauty
  • Global Market Prospects & Outlook
  • Physician-Dispensed Skin Care Products Lead the Global Market
  • Developed Regions Lead, Developing Economies to Spearhead Future Growth
  • Recent Market Activity
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
  • Myriad Benefits of Physician Dispensing of Cosmeceuticals Drives Market Growth
  • Growth in the Global Cosmeceuticals Market Bodes Well for Physician-Dispensed Products
  • Aging Population Emerges as a Key Demographic Driver of Growth in the Physician-Dispensed Cosmeceuticals Market
  • Global Aging Population Statistics for the 65+ Age Group in Million by Geographic Region for the Years 2019, 2025, 2035 and 2050
  • Elderly Population (65+ Years) as a % of Total Population by Developed, Less Developed and Least Developed Regions: 2019 & 2030
  • Societal Pressure to Look Young Peps Demand for Facial Aesthetics
  • Undesirable Side Effects: A Challenge to Reckon With
  • Anti-Aging Products: The Prime Category in the Physician-Dispensed Cosmeceuticals Market
  • Global Anti-Aging Cosmetics Market for the Years 2018, 2020, 2022 and 2024
  • Major Anti-Aging Ingredients of Cosmeceuticals
  • Cosmeceuticals with Biologically Active Ingredients to Improve Skin Functioning Begin to Find Favor
  • Increased Focus on Skin Microbiome Paves Way for New Generation Skincare Products
  • Cosmeceuticals Receive Boost from Introduction of Lipid Nanoparticles
  • Skin Brightening and Lightening Products: Significant Opportunities for Growth
  • Stem Cell Products Transform Market
  • Select Popular Stem Cell Beauty Products
  • Botulinum Toxin: The Preferred Solution in Facial Injectables Market
  • Cosmetic Botulinum Toxin Procedures Performed Worldwide: Percentage Breakdown of Procedure Volume by Gender for 2020E
  • Factors Propelling the Cosmetic Botox Market: In a Nut Shell
  • Millennials: A Popular Demographic Group for Botulinum Toxin
  • Cosmetic Botulinum Toxin Procedures Performed Worldwide: Percentage Breakdown of Procedure Volume by Age Group for 2019
  • Cosmeceutical Consumers: A Highly Informed, Aesthetically-Conscious Group
  • Rise in Young Population and Skin Conditions Such as Acne Drive Demand
  • Women Account for Highest Spends on Skin Care
  • Women as % of Total Labor Force in Select Countries: 2019
  • Growing Trend towards Cosmeceuticals with Natural Ingredients
  • Focus on Finding Alternatives to Hydroquinone for Pigment Control Purposes
  • Manufacturers Widen Customer Base
  • Physician Dispensing of Cosmeceuticals Remains a Contentious Topic
  • Distribution Scenario
  • E-Commerce Channels Reinforce Sales of Physician Dispensed Products
  • Percentage Share of Online Channel in Health and Beauty Sector: 2020 and 2025
  • Social Networking Emerges as an Effective Marketing Tool in the Beauty Space
  • An Insight into Notable Barriers to Market Growth
4. GLOBAL MARKET PERSPECTIVE
  • TABLE 1: World Recent Past, Current & Future Analysis for Physician Dispensed Cosmeceuticals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
  • TABLE 2: World Historic Review for Physician Dispensed Cosmeceuticals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • TABLE 3: World 16-Year Perspective for Physician Dispensed Cosmeceuticals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2023 & 2030
  • TABLE 4: World Recent Past, Current & Future Analysis for Skin Care by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
  • TABLE 5: World Historic Review for Skin Care by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • TABLE 6: World 16-Year Perspective for Skin Care by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2023 & 2030
  • TABLE 7: World Recent Past, Current & Future Analysis for Hair Care by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
  • TABLE 8: World Historic Review for Hair Care by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • TABLE 9: World 16-Year Perspective for Hair Care by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2023 & 2030
  • TABLE 10: World Recent Past, Current & Future Analysis for Eye Care by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
  • TABLE 11: World Historic Review for Eye Care by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • TABLE 12: World 16-Year Perspective for Eye Care by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2023 & 2030
  • TABLE 13: World Recent Past, Current & Future Analysis for Other Product Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
  • TABLE 14: World Historic Review for Other Product Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • TABLE 15: World 16-Year Perspective for Other Product Types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2023 & 2030
  • TABLE 16: World Recent Past, Current & Future Analysis for Hospital Pharmacies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
  • TABLE 17: World Historic Review for Hospital Pharmacies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • TABLE 18: World 16-Year Perspective for Hospital Pharmacies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2023 & 2030
  • TABLE 19: World Recent Past, Current & Future Analysis for Retail Pharmacies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
  • TABLE 20: World Historic Review for Retail Pharmacies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • TABLE 21: World 16-Year Perspective for Retail Pharmacies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2023 & 2030
  • TABLE 22: World Recent Past, Current & Future Analysis for Other Distribution Channels by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
  • TABLE 23: World Historic Review for Other Distribution Channels by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • TABLE 24: World 16-Year Perspective for Other Distribution Channels by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2023 & 2030
  • TABLE 25: World Physician Dispensed Cosmeceuticals Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030
III. MARKET ANALYSIS
  • UNITED STATES
  • Physician Dispensed Cosmeceuticals Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2023 (E)
  • United States: A Major Market for Physician Dispensed Cosmeceuticals
  • Anti-Aging Cosmeceuticals and Sunscreens to Drive Growth
  • Baby-Boomers and Working Females Propel Demand for Skin Care Products
  • US Population by Age Group: Percentage Breakdown of Population by Age Group (2020)
  • North American Aging Population by Age Group: 1975-2050
  • Increasing Demand for Cosmetic Treatments Augurs Well for the Market
  • Hydroquinone-free Products Attract Attention
  • CANADA
  • Anti-Aging Cosmeceutical Products: Market Overview
  • JAPAN
  • Market Overview
  • CHINA
  • Market Overview
  • Aging Population Fuels Market Prospects
  • EUROPE
  • Physician Dispensed Cosmeceuticals Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2023 (E)
  • Market Overview
  • FRANCE
  • GERMANY
  • ITALY
  • UNITED KINGDOM
  • SPAIN
  • RUSSIA
  • REST OF EUROPE
  • ASIA-PACIFIC
  • Market Overview
  • AUSTRALIA
  • INDIA
  • Market Overview
  • SOUTH KOREA
  • REST OF ASIA-PACIFIC
  • LATIN AMERICA
  • Market Overview
  • ARGENTINA
  • BRAZIL
  • Market Overview
  • MEXICO
  • REST OF LATIN AMERICA
  • MIDDLE EAST
  • IRAN
  • ISRAEL
  • SAUDI ARABIA
  • UNITED ARAB EMIRATES
  • REST OF MIDDLE EAST
  • AFRICA
IV. COMPETITION

Companies Mentioned

A selection of companies mentioned in this report includes:

  • Allergan Aesthetics
  • Cardinal Health, Inc.
  • Bayer AG
  • Amway Corporation
  • Beiersdorf AG
  • Clinique Laboratories LLC
  • Allergan PLC
  • Cosmeceuticals International Inc.
  • Cellex-C International, Inc.
  • ALASTIN Skincare, Inc.
  • A. Menarini Asia-Pacific Holdings Pte., Ltd.
  • Athena Cosmetics, Inc.
  • Cosmedical Technologies LLC
  • Bausch Health Companies Inc.
  • Cosmetic Skin Solutions LLC